Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Artivion to acquire Endospan for $335 million

PUBLIC · AORTMay 18, 2026•3 months ago

Acquiring Company

Artivion

Acquired Company

Endospan

Kennesaw

Tel Aviv DistrictManufacturingBiotechnologyHealthcareHealth CareMedicalMedical DeviceBiotechnologyHealth CareMedical Device

Description

Artivion is set to acquire full ownership of Endospan for approximately $135 million, with potential additional payments of up to $200 million. This acquisition follows FDA approval of Endospan’s Nexus system for aortic arch treatments. The transaction will be completed in cash and is subject to customary closing conditions.

Company Information

Company

Artivion

Location

1655 ROBERTS BOULEVARD N W

Kennesaw, Georgia, United States

About

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Don't miss Artivion's next move

Get an email the moment Artivion makes an acquisition, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Artivion's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Endospan?

Endospan was acquired by Artivion, based in Kennesaw. The deal was reported on May 18, 2026. Headquartered in suburban Atlanta, Georgia, Artivion, Inc. Artivion is publicly traded (AORT) and operates in Manufacturing.

When did Artivion acquire Endospan?

Artivion's acquisition of Endospan was reported on May 18, 2026. Artivion is set to acquire full ownership of Endospan for approximately $135 million, with potential additional payments of up to $200 million. This acquisition follows FDA approval of Endospan’s Nexus system for aortic arch treatments. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Endospan do?

Endospan is a pioneer in endovascular solutions for aortic arch disease, specializing in the repair of aneurysms and dissections. It is privately held, operating in Biotechnology, and is based in Tel Aviv District.